RegMedNet eBook: explore raw materials for CAR-T production
Take a look at this eBook from RegMedNet exploring CAR-T therapies, including different strategies that could help overcome manufacturing obstacles. Highlights include a Special Report on Engineering chimeric antigen receptor-natural killer cells for cancer immunotherapy and a Review article on Chimeric antigen receptor T cells immunotherapy for hematological malignancies.
Contents include:
[REVIEW] Chimeric antigen receptor T cells immunotherapy: challenges and opportunities in hematological malignancies- [REVIEW] Implications of T cell receptor biology on the development of new T cell therapies for cancer
- [SPECIAL REPORT] Engineering chimeric antigen receptor-natural killer cells for cancer immunotherapy
- [OPINION] Why it’s important to avoid the use of serum in your CAR-T manufacturing process
- [INFOGRAPHIC] How different parameters influence your final CAR-T cell product
- [INFOGRAPHIC] How to choose the best T-cell medium for your CAR-T cell manufacturing process
